Cor Therapeutics - was ist da los? - 500 Beiträge pro Seite

[kathan]

Hat jemand `ne Ahnung warum es da heute so dunkelrot ausschaut? Habe noch keine Meldung oder ähnliches gefunden?

Schönen Abend allerseits - Gruß, Kathan

[orawan]

Gewinnwarnung für 3. Quartal, siehe yahoo.finance

[puhvogel]

COR Therapeutics, Inc. Resets Guidance for Third Quarter and Year-End 2001
SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--Oct. 3, 2001--COR Therapeutics, Inc. announced today that third quarter sales of INTEGRILIN® (eptifibatide) Injection to wholesalers in the United States will be lower than previously anticipated.

The Company said it expects U.S. sales to wholesalers to be approximately $53 million and worldwide sales to be approximately $59 million for the third quarter of 2001, primarily due to less than anticipated demand in September.

The Company provided new earnings per share guidance for the third quarter of $0.01. For 2001, COR indicated that its new guidance for worldwide sales of INTEGRILIN is $240 to $250 million, and that earnings per share are expected to be $0.11 to $0.13, excluding a possible $10 million milestone payment related to European regulatory approval in angioplasty. The new earnings per share estimates for the quarter and year-end also reflect lower interest income on investments.

COR said that U.S. hospital-based sales for July and August, according to third-party data, were in line with expectations. The Company also noted that in a growing market, patient share for INTEGRILIN increased to over 51 percent in August, the highest ever reported by COR.